The FDA backtracks but still eyes the iceberg...
July 21, 2026View Online | Sign Up | Shop
Newsletter Logo

Presented By

Sponsor Logo: Cytonics

Just brew it. We, a newsletter named for your favorite morning beverage, are delighted to report that the American Heart Association (AHA) has deemed it safe—and even potentially beneficial—for most adults to drink up to five cups of coffee per day. In addition to keeping you awake at that 9am meeting, the AHA said the ~400 milligrams of caffeine from three to five cups of joe has been linked to a lower risk of heart disease, stroke, and Type 2 diabetes. However, the AHA did not mention what being around a colleague who just downed five cups of coffee does to your blood pressure.

Dave Lozo, Sam Klebanov, Molly Liebergall, Matty Merritt, Neal Freyman, Abby Rubenstein

In today’s newsletter, we’ll get into:

  • The latest on lettuce
  • New tariffs on Canada
  • Why getting a little culture might help you live longer

Markets

Nasdaq

25,508.07

S&P

7,443.28

Dow

51,839.26

10-Year

4.598%

Bitcoin

$65,282.89

Alphabet

$351.99

Data is provided by

*Stock data as of market close, cryptocurrency data as of 5:30pm ET. Here's what these numbers mean.

Markets: With oil prices volatile after a weekend of escalation between the US and Iran, stocks fell yesterday like the lip balm that didn’t quite make it all the way back into your pocket. Google, which is among the Big Tech companies reporting earnings this week, rose amid reports that it’s developing a new AI chip.

Markets Sponsored by Cytonics

Final days to invest: Cytonics aims to crack a $560b market with what could be the first and only potential cure for osteoarthritis. Join 7,500+ shareholders and invest before this month’s deadline.

EXPLOSIVE (DIARRHEA) UPDATES

FDA’s false positive doesn’t clear Taylor Farms

Packages of Taylor Farms salad kits in grocery store

Justin Sullivan/Getty Images

The FDA said “lettuce get this right.” The agency retracted its claim that it had found the sickness-causing cyclospora parasite in a sample of Taylor Farms lettuce over the weekend, saying yesterday that the test was a false positive. But don’t go preparing that salad kit in your fridge just yet—the FDA still believes the company’s iceberg lettuce is linked to the multi-state outbreak.

Here’s what we know about the illness’s probable connection between the company whose clients include Walmart, Whole Foods, Costco, Taco Bell, and McDonald’s and the gastrointestinal ailment that’s got Americans straddling toilets in agony:

  • Last week, the outbreak of explosive diarrhea (as if there’s any other kind) was linked to shredded lettuce from a single supplier to Taco Bell restaurants in five states.
  • On Friday, Taylor Farms issued a voluntary recall of its iceberg lettuce grown in central Mexico that was sold between June 29 and July 16 across 27 states. The recall remains in place.
  • Despite the false positive, the FDA clarified yesterday that, unlike the Titanic captain, it still considers the iceberg a serious problem. “FDA’s traceback investigation and outbreak data continue to converge on shredded iceberg lettuce from Taylor Farms locations in central Mexico,” the agency said in a statement.

In its own statement, Taylor Farms said that the FDA “apologized to us” for the false positive, noting that besides the lettuce from Mexico, “all other Taylor Farms products…are not involved in the recall.”

How did the false positive happen?

An expert told the Wall Street Journal that cyclospora is impossible to grow in a lab, making it harder to study and link to a common source because scientists can’t culture more of it to test.

Another scientist interviewed by MarketWatch said the complex nature of the pathogen could have resulted in the test detecting a similar organism.

More cases are likely coming: As of July 15, the FDA said there have been more than 1,600 confirmed cyclospora cases in the US and another 5,100+ it is working to confirm.—DL

Sponsored By Cytonics

The next-gen treatment targeting a $560b disease

Sponsor: Cytonics

Osteoarthritis is one of the world’s most common diseases, with over $560 billion spent managing its symptoms each year. But soon, its 500+ million patients* may be able to do more than that.

An emerging biotech company called Cytonics may have discovered what soon could be osteoarthritis’s first potential cure.

They successfully cleared phase 1 clinical trials with a perfect safety profile.** Now, Cytonics is gearing up for the next phase on a version engineered to be 200% more potent.

Potential medical breakthroughs like this are rare. Even rarer? You can invest in Cytonics as they prepare for the next phase.

But the opportunity to invest ends next week. Become a Cytonics shareholder before next week’s deadline.

World

Tour de headlines

American and Canadian flags flying together

Geoff Robins/Getty Images